Cargando…

lncRNA CDKN2B-AS1 Could Be an Indicator to Identify Prognosis and Status of Immune Microenvironment in Thyroid Cancer

Thyroid cancer (TC) is prone to recurrence, and biomarkers for predicting progression-free interval (PFI) are poorly explored. The study investigates the predictive value and underlying biological mechanisms of lncRNA CDKN2B-AS1 in TC. Combining RNA-seq and survival data, we identified that CDKN2B-A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Cheng, Yi, Cheng, Lin, Haiyang, Zhao, Jiajia, Yuan, Junhui, Chen, Yongzheng, Chen, Haibing, Lin, Li, Zhao, Yisha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012630/ https://www.ncbi.nlm.nih.gov/pubmed/35432631 http://dx.doi.org/10.1155/2022/4317480

Ejemplares similares

Genomic Instability-Related LncRNA Signature Predicts the Prognosis and Highlights LINC01614 Is a Tumor Microenvironment-Related Oncogenic lncRNA of Papillary Thyroid Carcinoma
por: Dong, Xubin, et al.
Publicado: (2021)

An exosome-related lncRNA signature correlates with prognosis, immune microenvironment, and therapeutic responses in hepatocellular carcinoma
por: Peng, Wang, et al.
Publicado: (2023)

Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma
por: Xu, Shengchao, et al.
Publicado: (2021)

A new acidic microenvironment related lncRNA signature predicts the prognosis of liver cancer patients
por: Jiang, Peng, et al.
Publicado: (2022)

lncRNA HEIH, an indicator of high malignancy and poor prognosis, functions as an oncogene in breast cancer
por: Chen, Cheng, et al.
Publicado: (2020)

Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
por: Chen, Cong, et al.
Publicado: (2022)

A Necroptosis-Related lncRNA Signature Predicts Prognosis and Indicates the Immune Microenvironment in Soft Tissue Sarcomas
por: Liu, Binfeng, et al.
Publicado: (2022)

Construction of an Immune-Related lncRNA Signature That Predicts Prognosis and Immune Microenvironment in Osteosarcoma Patients
por: He, Yi, et al.
Publicado: (2022)

Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Fang, Chongkai, et al.
Publicado: (2022)

An angiogenesis-related lncRNA signature predicts the immune microenvironment and prognosis of breast cancer
por: Wang, Ya-Wen, et al.
Publicado: (2023)

ANRIL: A lncRNA at the CDKN2A/B Locus With Roles in Cancer and Metabolic Disease
por: Kong, Yahui, et al.
Publicado: (2018)

LncRNA LINC01207 Could Positively Regulate the Development of Colorectal Cancer
por: Hu, Gaowu, et al.
Publicado: (2023)

Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma
por: Jiang, Fan, et al.
Publicado: (2022)

A Novel Defined Endoplasmic Reticulum Stress-Related lncRNA Signature for Prognosis Prediction and Immune Therapy in Glioma
por: Zheng, Yinfei, et al.
Publicado: (2022)

The LncRNA DUXAP10 Could Function as a Promising Oncogene in Human Cancer
por: Zhao, Junjie, et al.
Publicado: (2022)

LncRNA HOTAIR in Tumor Microenvironment: What Role?
por: Botti, Gerardo, et al.
Publicado: (2019)

Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma
por: Wang, Kun, et al.
Publicado: (2020)

LncRNA SNHG16 drives proliferation and invasion of papillary thyroid cancer through modulation of miR-497
por: Wen, Qiang, et al.
Publicado: (2019)

A disulfidptosis-related lncRNA index predicting prognosis and the tumor microenvironment in colorectal cancer
por: Xiao, Lijun, et al.
Publicado: (2023)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway
por: Zhao, Qing, et al.
Publicado: (2021)

Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Bai, Yang, et al.
Publicado: (2021)

Ferroptosis-Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma
por: Zhu, Jiahao, et al.
Publicado: (2022)

An m7G-related lncRNA signature predicts prognosis and reveals the immune microenvironment in bladder cancer
por: Li, Zhenchi, et al.
Publicado: (2023)

Integrated analysis of hypoxia-associated lncRNA signature to predict prognosis and immune microenvironment of lung adenocarcinoma patients
por: Shao, Jun, et al.
Publicado: (2021)

LncRNA NEAT1 suppresses cellular senescence in hepatocellular carcinoma via KIF11‐dependent repression of CDKN2A
por: Chen, Danlei, et al.
Publicado: (2023)

LncRNA CRNDE promotes the progression and angiogenesis of pancreatic cancer via miR-451a/CDKN2D axis
por: Zhu, Hong-Yan, et al.
Publicado: (2021)

Effect of 9p21.3 (lncRNA and CDKN2A/2B) variant on lipid profile
por: Wei, Baozhu, et al.
Publicado: (2022)

Circulating lncRNA BC030099 Increases in Preeclampsia Patients
por: Sun, Yuhong, et al.
Publicado: (2019)

Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
por: Jiang, Zi-Rong, et al.
Publicado: (2022)

Development of Prognostic Indicator Based on Autophagy-Related lncRNA Analysis in Colon Adenocarcinoma
por: Zhou, Weige, et al.
Publicado: (2020)

Super-enhancer-driven lncRNA LIMD1-AS1 activated by CDK7 promotes glioma progression
por: Chen, Zhigang, et al.
Publicado: (2023)

Down-regulation of lncRNA-NEF indicates poor prognosis in intrahepatic cholangiocarcinoma
por: Liang, Zhanqiang, et al.
Publicado: (2019)

LncRNA PVT1 Acts as a Tumor Promoter in Thyroid Cancer and Promotes Tumor Progression by Mediating miR-423-5p-PAK3
por: Lin, Qiu-Yu, et al.
Publicado: (2020)

LncRNA NEAT1 Promotes High Glucose-Induced Mesangial Cell Hypertrophy by Targeting miR-222-3p/CDKN1B Axis
por: Liao, Lin, et al.
Publicado: (2021)

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
por: Yang, Mingyi, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature to predict prognosis and immune microenvironment of colon adenocarcinoma
por: Li, Dongming, et al.
Publicado: (2023)

An Angiogenesis-Related lncRNA Signature Is Associated with Prognosis and Tumor Immune Microenvironment in Breast Cancer
por: Gao, Shun, et al.
Publicado: (2023)

A Novel Oxidative Stress-Related lncRNA Signature That Predicts the Prognosis and Tumor Immune Microenvironment of Breast Cancer
por: Zhao, Jinlai, et al.
Publicado: (2022)

A New lncRNA, APTR, Associates with and Represses the CDKN1A/p21 Promoter by Recruiting Polycomb Proteins
por: Negishi, Masamitsu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cbq47cpekjmu0n9d1cr7b28805